1-3 of 3
Riccardo Caccialanza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HLA-DQ8 Haplotype Increases the Risk of Relapse after Allogeneic Stem Cell Transplantation Possibly Affecting Graft-Versus-Leukemia: A Single-Center Study on 400 Patients

Giulia Losi, Annamaria Pasi, Carmen Tania Prezioso, Bianchessi Antonio, Caterina Zerbi, Irene Defrancesco, Anna Amelia Colombo, Francesco Romano, Valentina Da Prat, Alessia Taurino, Valentina Zoboli, Luca Arcaini, Cesare Perotti, Riccardo Caccialanza, Nicola Polverelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 2168.
https://doi.org/10.1182/blood-2024-207802
Published: 2024
Journal Articles

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)

Clinical Trials & Observations Brief Report
Giovanni Palladini, Vittorio Perfetti, Stefano Perlini, Laura Obici, Francesca Lavatelli, Riccardo Caccialanza, Rosangela Invernizzi, Benedetto Comotti, Giampaolo Merlini
Journal: Blood
Blood (2005) 105 (7): 2949–2951.
https://doi.org/10.1182/blood-2004-08-3231
Published: 2005
Journal Articles

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation

Clinical Trials & Observations Brief Report
Giovanni Palladini, Vittorio Perfetti, Laura Obici, Riccardo Caccialanza, Alessandra Semino, Fausto Adami, Giobatta Cavallero, Roberto Rustichelli, Giovambattista Virga, Giampaolo Merlini
Journal: Blood
Blood (2004) 103 (8): 2936–2938.
https://doi.org/10.1182/blood-2003-08-2788
Published: 2004